Aytu BioPharma(AYTU)
2.85 0.03 1.0638%
| 今开：2.81 | 昨收：2.82 |
| 最高：2.85 | 最低：2.78 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.7021132E7 |
Aytu BioPharma的热门讨论
股东委托书协议
Aytu BioPharma(AYTU)05-11 04:15
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-24-016003 Act: 34 Size: 1 MB 网页链接查看全文
当期报告
Aytu BioPharma(AYTU)06-18 20:15
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01, 2.03, 7.01, 8.01, and 9.01 Accession Number: 0001437749-24-020590 Act: 34 Size: 1 MB 网页链接查看全文
持股变动声明
Aytu BioPharma(AYTU)07-03 05:25
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-24-000527 Size: 6 KB 网页链接查看全文
季度财报
Aytu BioPharma(AYTU)05-16 04:25
$Aytu BioPharma(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-017051 Act: 34 Size: 8 MB 网页链接查看全文
当期报告
Aytu BioPharma(AYTU)05-16 04:25
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-017058 Act: 34 Size: 482 KB 网页链接查看全文
其他
Aytu BioPharma(AYTU)05-11 04:15
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-24-016004 Act: 34 Size: 544 KB 网页链接查看全文
超过5%股东持股披露「修订」
Aytu BioPharma(AYTU)06-19 17:27
$Aytu BioPharma(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-072841 Act: 34 Size: 63 KB 网页链接查看全文
其他
Aytu BioPharma(AYTU)05-11 04:15
$Aytu BioPharma(AYTU)$ ARS Annual Report to Security Holders Accession Number: 0001437749-24-016006 Act: 34 Size: 1 MB 网页链接查看全文
持股变动声明
Aytu BioPharma(AYTU)06-19 17:26
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-072893 Size: 12 KB 网页链接查看全文
Aytu BioPharma的最新讨论
![[哭泣]](http://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
![[滴汗]](http://js.xueqiu.com/ugc/images/face/emoji_13_coldsweat.png?v=1 "[滴汗]"){kind=small}
会跑的猪2020-07-16 23:19
$AMER BIO MEDICA(ABMC)$
这支股票是在OTC市场，如果是在纳斯达克，估值会比目前高的多。 同类的$Co-diagnostics(CODX)$ $Aytu BioScience(AYTU)$ ，可供参考。
网页链接查看全文
![[鼓鼓掌]](http://js.xueqiu.com/ugc/images/face/emoji_03_applaud.png?v=1 "[鼓鼓掌]"){kind=small}
![[大笑]](http://js.xueqiu.com/ugc/images/face/emoji_02_laughing.png?v=1 "[大笑]"){kind=small}
![[笑]](http://js.xueqiu.com/ugc/images/face/emoji_01_smile.png?v=1 "[笑]"){kind=small}
![[俏皮]](http://js.xueqiu.com/ugc/images/face/emoji_04_cool.png?v=1 "[俏皮]"){kind=small}
![[害羞]](http://js.xueqiu.com/ugc/images/face/emoji_21_shine.png?v=1 "[害羞]"){kind=small}
![[很赞]](http://js.xueqiu.com/ugc/images/face/emoji_35_like.png?v=1 "[很赞]"){kind=small}
![[干杯]](http://js.xueqiu.com/ugc/images/face/emoji_42_beer.png?v=1 "[干杯]"){kind=small}
![[主力]](http://js.xueqiu.com/ugc/images/face/emoji_45_force.png?v=1 "[主力]"){kind=small}
trade like a pro!Aytu BioPharma的新闻
美股异动丨Aytu BioPharma盘前大涨近19% 2023年Q1业绩超预期
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%，报0.23美元。公司2023年Q1财报实现营收2765.5万美元，前值为2189.7万美元，预期值为2430万美元，超出市场预期13.81%；每股收益为-0.06美元，前值为-0.33美元，预期值为-0.18美元，超出市场预期66.67%。 网页链接
Aytu BioPharma的公告
持股变动声明
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-24-000527 Size: 6 KB 网页链接
超过5%股东持股披露「修订」
$Aytu BioPharma(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-072841 Act: 34 Size: 63 KB 网页链接
持股变动声明
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-072893 Size: 12 KB 网页链接
当期报告
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01, 2.03, 7.01, 8.01, and 9.01 Accession Number: 0001437749-24-020590 Act: 34 Size: 1 MB 网页链接
季度财报
$Aytu BioPharma(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-017051 Act: 34 Size: 8 MB 网页链接
当期报告
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-017058 Act: 34 Size: 482 KB 网页链接
股东委托书协议
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-24-016003 Act: 34 Size: 1 MB 网页链接
其他
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-24-016004 Act: 34 Size: 544 KB 网页链接
其他
$Aytu BioPharma(AYTU)$ ARS Annual Report to Security Holders Accession Number: 0001437749-24-016006 Act: 34 Size: 1 MB 网页链接
持股变动声明
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-24-000340 Size: 7 KB 网页链接